Connection
Natalie Serkova to Drug Design
This is a "connection" page, showing publications Natalie Serkova has written about Drug Design.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.284 |
|
|
|
-
Serkova N, Boros LG. Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am J Pharmacogenomics. 2005; 5(5):293-302.
Score: 0.217
-
Serkova NJ, Spratlin JL, Eckhardt SG. NMR-based metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther. 2007 Dec; 9(6):572-85.
Score: 0.067